CITIZENS FINANCIAL GROUP INC/RI
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Capital
As a BHC and FHC, we are subject to regulation and supervision by the FRB. Our banking subsidiary, CBNA, is a national banking association primarily regulated by the OCC. Our regulation and supervision continues to evolve as the legal and regulatory frameworks governing our operations continue to change. See the “Regulation and Supervision” section in Item 1 for more information.
Capital Adequacy Process
Our assessment of capital adequacy begins with our Board-approved risk appetite and risk management framework. This framework provides for the identification, measurement, and management of material risks. Capital requirements are determined for actual and forecasted risk portfolios using applicable regulatory capital methodologies. The assessment also considers the possible impacts of approved and proposed changes to regulatory capital requirements. Key analytical frameworks, including scenario analysis and stress testing, supplement our base line forecast to help inform a range of potential outcomes. A governance framework supports our capital planning process, including capital management policies and procedures that document capital adequacy metrics and limits, as well as our Capital Contingency Plan and the active engagement of both the Board and senior management in oversight and decision-making.
Forward-looking assessments of capital adequacy provide for the development of a single capital plan, which is periodically submitted to the FRB, that covers both us and our banking subsidiary. We prepare this plan in accordance with the Capital Plan Rule and we participate annually in the FRB’s horizontal capital review as part of their normal supervisory process, which includes an assessment of specific capital planning areas.
Citizens Financial Group, Inc. | 70
The FRB regularly supervises and evaluates our capital adequacy and capital planning processes, including the submission of an annual capital plan approved by our Board of Directors or one of its committees. Under the FRB’s capital requirements, we must maintain capital ratios above the sum of the regulatory minimum and SCB requirement to avoid restrictions on capital distributions and discretionary bonus payments. The FRB utilizes the supervisory stress test to determine our SCB, which is re-calibrated with each biennial supervisory stress test and updated annually to reflect our planned common stock dividends. As an institution subject to Category IV standards, we are subject to biennial supervisory stress testing in even-numbered years. Our SCB associated with the 2024 supervisory stress test was 4.5%, effective through September 30, 2025. In August 2025, the FRB provided us with our updated SCB requirement, which remains at 4.5% and was initially effective from October 1, 2025 to September 30, 2026. However, in February 2026, the SCB effective date was moved from October 1, 2026 to October 1, 2027 because the FRB extended the notification deadlines while its enhanced transparency proposal and related stress test model changes remain under public comment and will not be finalized before the 2026 supervisory stress test, resulting in our SCB remaining in place until October 1, 2028, pending other regulatory actions.
Regulations relating to capital planning, regulatory reporting, stress testing, and capital buffer requirements applicable to firms like us are presently subject to rulemaking and potential further guidance and interpretation by the applicable federal regulators. We will continue to evaluate the impact of these and any other regulatory changes, including their potential resultant changes in our regulatory and compliance costs.
Regulatory Capital Ratios and Capital Composition
Under the current U.S. Basel III capital framework, we, and our banking subsidiary, CBNA, must meet the following specific minimum requirements: CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, Total capital ratio of 8.0%, and Tier 1 leverage ratio of 4.0%. As a BHC, our SCB of 4.5% is imposed on top of the three minimum risk-based capital ratios listed above and a CCB of 2.5% is imposed on top of the three minimum risk-based capital ratios listed above for CBNA.
For additional discussion of the U.S. Basel III capital framework and its related application, see the “Regulation and Supervision” section in Item 1. The table below presents the regulatory capital ratios for CFG and CBNA under the U.S. Basel III Standardized rules:
| Table 24: Regulatory Capital Ratios Under the U.S. Basel III Standardized Rules | ||||||
|---|---|---|---|---|---|---|
| December 31, | ||||||
| 2025 · 2024 | ||||||
| (dollars in millions) · Amount · Ratio · Amount · Ratio · Required Minimum Capital Ratio(1) | ||||||
| CET1 capital | ||||||
| CFG | $18,240 | 10.6% | $17,900 | 10.8% | 9.0% | |
| CBNA | 20,946 | 12.3 | 20,250 | 12.3 | 7.0 | |
| Tier 1 capital | ||||||
| CFG | 20,351 | 11.9 | 20,013 | 12.1 | 10.5 | |
| CBNA | 20,946 | 12.3 | 20,250 | 12.3 | 8.5 | |
| Total capital | ||||||
| CFG | 23,654 | 13.8 | 23,232 | 14.0 | 12.5 | |
| CBNA | 24,135 | 14.1 | 23,362 | 14.2 | 10.5 | |
| Tier 1 leverage | ||||||
| CFG | 20,351 | 9.5 | 20,013 | 9.4 | 4.0 | |
| CBNA | 20,946 | 9.8 | 20,250 | 9.6 | 4.0 | |
| Risk-weighted assets | ||||||
| CFG | 171,493 | 165,699 | ||||
| CBNA | 170,656 | 164,986 | ||||
| Quarterly adjusted average assets(2) | ||||||
| CFG | 215,321 | 212,555 | ||||
| CBNA | 214,310 | 211,849 | ||||
(1)Represents minimum requirement under the current capital framework plus the SCB of 4.5% and CCB of 2.5% for CFG and CBNA, respectively. The SCB and CCB are not applicable to the Tier 1 leverage ratio.
(2)Represents total average assets less certain amounts deducted from Tier 1 capital.
Citizens Financial Group, Inc. | 71
At December 31, 2025, CFG’s CET1, Tier 1, and Total capital ratios decreased compared to December 31, 2024. Dividends, common share repurchases, a $5.8 billion increase in RWA, and the full phase-in of the modified CECL transition amount was partially offset by net income. Higher commercial and industrial loans was the key driver for the increase in RWA.
At December 31, 2025, CBNA’s CET1 and Tier 1 capital ratios were stable and its Total capital ratio decreased slightly compared to December 31, 2024. Dividend payments to the Parent Company, a $5.7 billion increase in RWA, and the full phase-in of the modified CECL transition amount was partially offset by net income. Higher commercial and industrial loans was the key driver for the increase in RWA.
At December 31, 2025, CFG’s and CBNA’s Tier 1 leverage ratio increased compared to December 31, 2024, reflecting an increase in quarterly adjusted average assets and their respective changes in Tier 1 capital described above.
The following table presents the components of our regulatory capital under the U.S. Basel III capital framework:
| Table 25: Capital Composition Under the U.S. Basel III Capital Framework | ||
|---|---|---|
| December 31, | ||
| (dollars in millions) | 2025 | 2024 |
| Total common stockholders’ equity | $24,206 | $22,141 |
| Adjustments: | ||
| Modified CECL transitional amount | — | 96 |
| Net unrealized (gains)/losses recorded in AOCI, net of tax: | ||
| Debt securities | 1,603 | 2,369 |
| Derivatives | 118 | 925 |
| Unamortized net periodic benefit costs | 249 | 301 |
| Deductions: | ||
| Goodwill, net of deferred tax liability | (7,763) | (7,768) |
| Other intangible assets, net of deferred tax liability | (104) | (128) |
| Deferred tax assets that arise from tax loss and credit carryforwards | (69) | (36) |
| Total CET1 capital | 18,240 | 17,900 |
| Qualifying preferred stock | 2,111 | 2,113 |
| Total Tier 1 capital | 20,351 | 20,013 |
| Qualifying subordinated debt(1) | 1,239 | 1,232 |
| Allowance for credit losses | 2,183 | 2,259 |
| Exclusions from Tier 2 capital: | ||
| Modified adjusted allowance for credit losses transitional amount | — | (125) |
| Allowance on PCD assets | (119) | (147) |
| Adjusted allowance for credit losses | 2,064 | 1,987 |
| Total capital | $23,654 | $23,232 |
(1)As of December 31, 2024, the amount of non-qualifying subordinated debt excluded from regulatory capital was $469 million. See Note 11 for more details on our outstanding subordinated debt.
Capital Transactions
We completed the following capital transactions during 2025:
Repurchased $600 million of our outstanding common stock;
Issued 400,000 shares of 6.500% fixed-rate reset non-cumulative perpetual Series I Preferred Stock at an aggregate offering price of $400 million;
Redeemed all outstanding shares of the 5.650% fixed-rate reset non-cumulative perpetual Series F Preferred Stock on October 6, 2025;
Declared quarterly common stock dividends of $0.42 per share in the first three quarters and $0.46 in the fourth quarter, aggregating to $755 million; and
Declared preferred stock dividends aggregating to $138 million.
For additional detail regarding our common and preferred stock dividends see Note 15.
Citizens Financial Group, Inc. | 72
On June 13, 2025, we announced that our Board of Directors increased the capacity of our common share repurchase program to $1.5 billion, an increase of $1.2 billion above the $300 million of capacity remaining under the prior June 2024 authorization. All future capital distributions are subject to consideration and approval by our Board of Directors prior to execution. The timing and amount of future dividends and share repurchases will depend on various factors, including our capital position, financial performance, balance sheet growth, market conditions, and regulatory considerations.
AOCI Impact on Regulatory Capital
Under the current applicable regulatory capital rules we have made the AOCI opt-out election, which enables us to exclude components of AOCI from regulatory capital. As noted in the “Capital and Stress Testing Requirements” section of “Regulation and Supervision” in Item 1, the regulatory agencies are considering the inclusion of AOCI components in regulatory capital for Category IV firms like us, notably the AOCI relative to securities and pension.
In light of this potential change, the Company considers capital ratios including the AOCI impact from securities and pension when evaluating capital utilization and adequacy, in addition to capital ratios defined by the regulatory agencies. These capital ratios are intended to complement our regulatory capital ratios and are viewed by management as useful measures reflective of the level of capital available to withstand unexpected market conditions. See “Non-GAAP Financial Measures” for more information.
The following table presents our regulatory capital ratios including the AOCI impact from securities and pension:
| Table 26: AOCI Impact on Regulatory Capital | ||||||
|---|---|---|---|---|---|---|
| December 31, 2025 | ||||||
| CFG | CBNA | |||||
| (dollars in millions) | CET1 | Tier 1 | Total | CET1 | Tier 1 | Total |
| Regulatory capital, including AOCI impact: | ||||||
| Regulatory capital | $18,240 | $20,351 | $23,654 | $20,946 | $20,946 | $24,135 |
| Unrealized gains (losses) on securities and pension | (1,852) | (1,852) | (1,852) | (1,831) | (1,831) | (1,831) |
| Deferred tax assets - securities and pension AOCI | (37) | (37) | (37) | (39) | (39) | (39) |
| Regulatory capital, including AOCI impact (non-GAAP) | $16,351 | $18,462 | $21,765 | $19,076 | $19,076 | $22,265 |
| Risk-weighted assets, including AOCI impact: | ||||||
| Risk-weighted assets | $171,493 | $171,493 | $171,493 | $170,656 | $170,656 | $170,656 |
| Unrealized gains (losses) on securities and pension | (515) | (515) | (515) | (494) | (494) | (494) |
| Deferred tax assets - securities and pension AOCI | 1,491 | 1,491 | 1,491 | 1,469 | 1,469 | 1,469 |
| Risk-weighted assets, including AOCI impact (non-GAAP) | $172,469 | $172,469 | $172,469 | $171,631 | $171,631 | $171,631 |
| Ratio: | ||||||
| Regulatory capital ratio | 10.6% | 11.9% | 13.8% | 12.3% | 12.3% | 14.1% |
| Regulatory capital ratio, including AOCI impact (non-GAAP) | 9.5% | 10.7% | 12.6% | 11.1% | 11.1% | 13.0% |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.